Literature DB >> 24745676

Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells.

Hans-Peter Horny1, Karl Sotlar2, Peter Valent3.   

Abstract

Mastocytosis is a disease of bone marrow origin histologically characterized by compact tissue infiltrates of atypical mast cells never seen in reactive states. Most patients with mastocytosis have transformed mast cells carrying an activating point mutation at codon 816 of KIT and also show an elevated serum tryptase level. In this article immunophenotypical features of mast cells are described. Based on these features, mast cells are not closely related to other myeloid cells. Using the knowledge on aberrantly expressed antigens by mast cells, the hematopathologist should be able to recognize the disease even in the presence of unusual morphologic findings or an associated hematologic non-mast cell lineage disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD117; CD30; Immunophenotype; Mast cell; Mast cell leukemia; Mastocytosis; Systemic mastocytosis; Tryptase

Mesh:

Substances:

Year:  2014        PMID: 24745676      PMCID: PMC5798580          DOI: 10.1016/j.iac.2014.01.005

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  7 in total

1.  CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.

Authors:  Karl Sotlar; Hans-Peter Horny; Ingrid Simonitsch; Manuela Krokowski; Karl J Aichberger; Matthias Mayerhofer; Dieter Printz; Gerhard Fritsch; Peter Valent
Journal:  Am J Surg Pathol       Date:  2004-10       Impact factor: 6.394

Review 2.  Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.

Authors:  H-P Horny; K Sotlar; P Valent
Journal:  Pathobiology       Date:  2010-07-07       Impact factor: 4.342

3.  Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.

Authors:  Karl Sotlar; Sabine Cerny-Reiterer; Karina Petat-Dutter; Harald Hessel; Sabina Berezowska; Leonhard Müllauer; Peter Valent; Hans-Peter Horny
Journal:  Mod Pathol       Date:  2010-12-24       Impact factor: 7.842

Review 4.  Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Authors:  P Valent; H P Horny; L Escribano; B J Longley; C Y Li; L B Schwartz; G Marone; R Nuñez; C Akin; K Sotlar; W R Sperr; K Wolff; R D Brunning; R M Parwaresch; K F Austen; K Lennert; D D Metcalfe; J W Vardiman; J M Bennett
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

Review 5.  Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.

Authors:  Peter Valent; Sabine Cerny-Reiterer; Harald Herrmann; Irina Mirkina; Tracy I George; Karl Sotlar; Wolfgang R Sperr; Hans-Peter Horny
Journal:  Best Pract Res Clin Haematol       Date:  2010-08-12       Impact factor: 3.020

Review 6.  Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

Authors:  P Valent; C Akin; L Escribano; M Födinger; K Hartmann; K Brockow; M Castells; W R Sperr; H C Kluin-Nelemans; N A T Hamdy; O Lortholary; J Robyn; J van Doormaal; K Sotlar; A W Hauswirth; M Arock; O Hermine; A Hellmann; M Triggiani; M Niedoszytko; L B Schwartz; A Orfao; H-P Horny; D D Metcalfe
Journal:  Eur J Clin Invest       Date:  2007-06       Impact factor: 4.686

Review 7.  Mastocytosis: state of the art.

Authors:  Hans-Peter Horny; Karl Sotlar; Peter Valent
Journal:  Pathobiology       Date:  2007       Impact factor: 4.342

  7 in total
  4 in total

1.  Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.

Authors:  Katharina Blatt; Sabine Cerny-Reiterer; Juliana Schwaab; Karl Sotlar; Gregor Eisenwort; Gabriele Stefanzl; Gregor Hoermann; Matthias Mayerhofer; Mathias Schneeweiss; Sylvia Knapp; Thomas Rülicke; Emir Hadzijusufovic; Karin Bauer; Dubravka Smiljkovic; Michael Willmann; Andreas Reiter; Hans-Peter Horny; Peter Valent
Journal:  Blood       Date:  2015-10-20       Impact factor: 22.113

2.  Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Peter Horny; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2021-01-25       Impact factor: 4.304

3.  Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis.

Authors:  Aneta Szudy-Szczyrek; Oliwia Bachanek-Mitura; Tomasz Gromek; Karolina Chromik; Andrzej Mital; Michał Szczyrek; Witold Krupski; Justyna Szumiło; Zuzanna Kanduła; Grzegorz Helbig; Marek Hus
Journal:  J Clin Med       Date:  2021-03-07       Impact factor: 4.241

Review 4.  Mast Cells in the Mammalian Testis and Epididymis-Animal Models and Detection Methods.

Authors:  Marta Himelreich-Perić; Ana Katušić-Bojanac; Marko Hohšteter; Nino Sinčić; Vedrana Mužić-Radović; Davor Ježek
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.